NCT02590562 An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients. Status COMPLETED Phase N/A
NCT02586051 A Study of Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation Status COMPLETED Phase PHASE1
NCT02586025 Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer to Evaluate Treatment With Trastuzumab Plus (+) Pertuzumab + Docetaxel Compared With Trastuzumab + Placebo + Docetaxel Status COMPLETED Phase PHASE3
NCT02582983 A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) Infection Status COMPLETED Phase PHASE4
NCT02582970 A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum Status COMPLETED Phase PHASE4
NCT02581423 A Study of Capecitabine (Xeloda) in the Adjuvant Treatment of Participants With Resected Colon Cancer Status COMPLETED Phase PHASE4
NCT02580799 Study of Human Epidermal Growth Receptor (HER2) Status Evaluation in Breast Cancer Pathology Samples Status COMPLETED Phase N/A
NCT02576964 A Study of Capecitabine (Xeloda) and Peginterferon Alfa-2a (Pegasys) in Treatment-Naive Participants With Advanced Liver Cancer Status COMPLETED Phase PHASE2
NCT02576145 A Study to Assess Immune Response in Pediatric Kidney Transplant Recipients Treated With Daclizumab (Zenapax) Status COMPLETED Phase PHASE4
NCT02573025 A Bioequivalence Study of Pegylated Interferon Alfa-2a (PEG-IFN Alfa-2a) Benzyl Alcohol (BA)-Free Formulation Versus PEG-IFN Alfa-2a (Pegasys) Following Subcutaneous Administration Status COMPLETED Phase PHASE1
NCT02573012 Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Participants Status COMPLETED Phase PHASE4
NCT02570191 A Study of PEGASYS (Peginterferon Alfa-2a [40KD]) in Patients With Hepatitis B e Antigen (HBeAg)-Negative Chronic Hepatitis B Virus (HBV) Status COMPLETED Phase PHASE4
NCT02569996 A Study of Long-Term Rituximab (MabThera) Maintenance Therapy in Participants With Advanced Follicular Lymphoma Status COMPLETED Phase PHASE3
NCT02569515 A Study of Epoetin Beta (NeoRecormon) in Predialysis Patients With Renal Anemia Status COMPLETED Phase PHASE4
NCT02569502 A Study of Enfuvirtide (Fuzeon) in Patients With Advanced Human Immunodeficiency Virus-1 (HIV-1) Infection Status COMPLETED Phase PHASE4
NCT02568267 Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02567331 A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE4
NCT02567188 A Study of MIRCERA in Participants With Chronic Kidney Disease Stage 3-4 and Not on Dialysis Status COMPLETED Phase N/A
NCT02565641 A Study of Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT02564770 A Retrospective Chart Review of MabThera (Rituximab) Treatment in Rheumatoid Arthritis (RA) Participants in Australia Status COMPLETED Phase N/A